Insights

LMG Life Sciences Ranks Choate Tier 1 and Names Six Life Sciences Stars

Six Choate attorneys and two practice areas have been ranked in this year’s LMG Life Sciences U.S. Firm and Attorney Rankings. The firm received a Tier 1 ranking in the areas of Patent Prosecution and Patent Strategy & Management, while Brenda Jarrell, Charles Lyon, Eric Marandett, Rolando Medina, Stephanie Schonewald, and Tobin Sullivan have been named Life Sciences Stars.

Choate Attorneys Recognized in Best Lawyers in America® 2024

Best Lawyers in America® has recognized 43 Choate attorneys in its 2024 edition, including naming 4 partners as Lawyer of the Year in Boston for their respective practice areas.

Choate Receives High Rankings for Patent Work from Managing IP 2023

Managing IP’s 2023 rankings of firms for patent litigation and protection work recognizes seven attorneys and Choate regionally and nationally for its work in the areas of patent prosecution, patent disputes and life sciences.

Choate Receives High Accolades in 2023 IAM Patent 1000

Ten Choate attorneys have been recognized in the 2023 IAM Patent 1000: The World’s Leading Patent Professionals, and the firm is one of three firms to receive a “Silver” ranking for patent litigation, placing it in the top six in Massachusetts, and one of only four firms to be “Highly Recommended” in patent prosecution.

Choate Ranks Highly in 2023 Legal 500

The 2023 edition of The Legal 500 recognized 29 Choate attorneys in their respective fields and 12 practice areas, with education and middle-market M&A receiving Tier 1 rankings.

Choate Lawyers and Practice Groups Recognized by Chambers 2023

The 2023 edition of Chambers USA Guide to America’s Leading Lawyers for Business recognized 16 practice areas and 31 Choate attorneys as leading counsel in their fields, with six receiving Band 1 rankings, three receiving nationwide recognition, two global recognitions, and two senior statesmen.

Bain Capital Life Sciences Leads $107M Series C Financing of Jnana Therapeutics

Choate represented Bain Capital Life Sciences in the $107M Series C Financing of Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets.

Benchmark Litigation 2023 Names Choate and Fifteen Attorneys as Stars

Choate receives high rankings in Benchmark Litigation’s annual survey of the top attorneys and law firms in the United States. 

Bain Capital Life Sciences Leads $100M Series C Financing in JenaValve

Choate represented Bain Capital Life Sciences as the lead investor in a $100M Series C financing in JenaValve Technology.